Generic statins and angiotensin receptor blockers typically used for heart disease also have the potential to bolster the immune systems of patients with Ebola virus and other life-threatening ...

Last week the first treatment for any kind of Ebola, a triple monoclonal antibody combination designed to treat the most severe ‘Zaire’ form of the virus, was approved by the FDA. The company behind ...

Ebola virus can pass from animals to humans, and between people through direct contact with infected fluids or tissues. Rarely, it causes outbreaks but when it does, they can lead to severe illness, ...

The FDA has announced its first approval for an Ebola treatment that can be used with both pediatric and adult patients infected by Zaire ebolavirus. The treatment is called Inmazeb; it is comprised ...

Recently, the FDA formally approved the first vaccine to prevent the Ebola virus. The advance comes at a crucial time, as Democratic Republic of Congo is suffering an outbreak that has lasted over a ...

Westchester’s Regeneron Pharmaceuticals announced on Monday that a study testing the company’s new Ebola virus treatment has been terminated early — because the company’s antibody cocktail has ...

Giving experimental treatments to patients infected with Ebola in West Africa is, indeed, the ethical thing to do, even though the risks and benefits of these treatments are unknown, a panel of ...

Ebola virus has caused several major outbreaks in recent decades. As a deadly hemorrhagic fever, its high death rate and disturbing symptoms have made it a feared disease. Scientists have now found ...

MIAMI--(BUSINESS WIRE)--Ridgeback Biotherapeutics LP (“Ridgeback”), a biotechnology company experienced in antiviral drug development, today announced the U.S. Food and Drug Administration (FDA) has ...